89 results on '"Gil, Thierry"'
Search Results
2. Technology Dependence of Stuck Bits and Single-Event Upsets in 110-, 72-, and 63-nm SDRAMs
3. Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel
4. Efficacy and safety of abiraterone acetate plus prednisone and androgen deprivation therapy +/- docetaxel in older patients (≥70 years), with de novo metastatic-castration sensitive prostate cancer, compared to younger patients (<70 years): The PEACE-1 trial.
5. Réseaux de neurones oscillants pour des calculs économes en énergie
6. Oscillatory Neural Network for Edge Computing: A Mobile Robot Obstacle Avoidance Application
7. Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
8. On-Chip Learning with a 15-neuron Digital Oscillatory Neural Network Implemented on ZYNQ Processor
9. Oscillatory Neural Networks for Obstacle Avoidance on Mobile Surveillance Robot E4
10. Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer: AURA (Oncodistinct-004) trial.
11. How Frequency Injection Locking Can Train Oscillatory Neural Networks to Compute in Phase
12. Ab Initio Computer Simulations on Interfacial Properties of Single-Layer MoS2 and Au Contacts for Two-Dimensional Nanodevices
13. Oscillatory Neural Network as Hetero-Associative Memory for Image Edge Detection
14. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
15. A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma
16. A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring After Combination Therapy With Nivolumab and Cabozantinib in a Patient With Renal Carcinoma
17. Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)
18. 68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
19. Dedicated Wearable Sensitive Strain Sensor, Based on Carbon Nanotubes, for Monitoring the Rat Respiration Rate
20. Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
21. Digital Implementation of Oscillatory Neural Network for Image Recognition Applications
22. Oscillatory Neural Networks for Edge AI Computing
23. Exploring 1D and 2D Nanomaterials for Health Monitoring Wearable Devices
24. Multi-Scale Modeling and Simulation Flow for Oscillatory Neural Networks for Edge Computing
25. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
26. 1D Nanomaterial‐Based Highly Stretchable Strain Sensors for Human Movement Monitoring and Human–Robotic Interactive Systems
27. Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel
28. COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab
29. Stretchable Strain Sensors for Human Movement Monitoring
30. Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery.
31. Prevalence and clinical impact of BRCA1/2 mutations in patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC).
32. Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
33. Review—Energy Autonomous Wearable Sensors for Smart Healthcare: A Review
34. Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response
35. Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients
36. Stuck and Weakened Bits in SDRAM from a Heavy-Ion Microbeam
37. Edge-Computing Perspectives with Reconfigurable Hardware
38. Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies
39. Efficacy and safety of lurbinectedin (PM1183) in Ewing sarcoma: Final results from a phase 2 study.
40. Avelumab as neoadjuvant therapy in subjects with muscle-invasive urothelial carcinoma (AURA trial).
41. Computing in the Fog with Reconfigurable Gateways
42. Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
43. Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study
44. Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC).
45. Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in patients with advanced renal cell carcinoma (RCC).
46. Clinical impact of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis o
47. 56 years-old, an old age for pure seminomatous germ cell tumor: Case report and Review of the literature
48. Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients
49. Testicular germ cell tumor: Short and long-term side effects of treatment among survivors
50. Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.